Larynx Transplant for Post-Laryngectomy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a larynx transplant (larynx allograft transplantation) to assist individuals who have lost their voice box or experience difficulties speaking, swallowing, or breathing. The goal is to determine if this transplant can safely and effectively restore these functions. Suitable candidates include those who have had their voice box removed or face severe larynx issues, such as difficulty speaking or breathing. As an unphased trial, this study provides a unique opportunity for patients to contribute to groundbreaking research that could significantly enhance quality of life.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, you must be able to be weaned to 10 mg/day or less of steroids, which suggests some medication adjustments might be necessary.
What prior data suggests that larynx allograft transplantation is safe?
Research shows that larynx transplants, which replace the voice box, offer a promising option for those who have lost theirs. However, safety concerns remain. In previous studies, some patients experienced serious complications after receiving the transplant. For example, after two years, 27% of patients had died, and some required removal of the transplanted voice box. While the procedure may offer benefits, understanding these risks is crucial. Prospective trial participants should discuss these points with their doctor.12345
Why are researchers excited about this trial?
Larynx allograft transplantation is unique because it offers the possibility of restoring a natural voice and breathing function for individuals who have undergone a laryngectomy, unlike current options like artificial voice prostheses or tracheoesophageal puncture, which can be limiting. Researchers are excited about this treatment because it involves transplanting a larynx from a donor, which could potentially restore normal speech and airway functions in a way that current prosthetic solutions cannot. This approach is groundbreaking, as it aims to address not only the physical aspects but also the quality of life factors for patients, offering a more holistic solution.
What evidence suggests that larynx allograft transplantation might be an effective treatment for severe laryngeal incompetence?
Research shows that a larynx transplant can help people speak and swallow again after their voice box is removed. Some studies have shown good results, with patients regaining these abilities, although breathing without assistance remains difficult. In some cases, patients experienced no major problems, but the new voice box didn't always function as expected. Experts believe this treatment could greatly improve life for those with serious voice box issues. Despite some challenges, the chance to speak and swallow again offers hope for patients.12367
Who Is on the Research Team?
David G Lott, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for adults over 18 who've been cancer-free for at least 5 years after head and neck cancer treatment. It's suitable for those with severe laryngeal dysfunction or needing a total laryngectomy while already on immunosuppression. Candidates must be able to consent and participate in pre-op training but can't join if they have recent substance abuse, uncontrolled diseases, obesity, or are pregnant.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Transplantation and Initial Recovery
Patients undergo cadaveric laryngotracheal transplantation and initial recovery, including monitoring for short-term complications and hospital stay
Follow-up
Participants are monitored for survival of the allograft, voice evaluation, pulmonary function, and ability to have tracheotomy tube decannulated
What Are the Treatments Tested in This Trial?
Interventions
- Larynx Allograft Transplantation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor